Open access
Antimicrobial Chemotherapy
Announcement
18 March 2021

Draft Genome Sequences of Three Penicillin-Resistant Neisseria gonorrhoeae Strains Isolated in Cincinnati, Ohio, in 1994

ABSTRACT

Here, we report the draft genome sequences of three penicillin-resistant Neisseria gonorrhoeae isolates. We include associated data on MICs and genetic relationships to other N. gonorrhoeae strains collected from across the United States. Resistance mutations known to contribute to reduced penicillin susceptibility are annotated in each genome.

ANNOUNCEMENT

Penicillin resistance in Neisseria gonorrhoeae can be gained through two mechanisms, inheritance of a plasmid-borne penicillinase (blaTEM-1) or acquisition of chromosomal mutations. However, the complete suite of causative mutations underlying chromosomal resistance has yet to be determined. Contributors have been identified in a chromosomally mediated resistant N. gonorrhoeae strain (CMRNG), FA6140, isolated from an infected individual in Durham, North Carolina, in 1983 (1) and include (i) mutations in penA encoding a penicillin-binding protein 2 (PBP2) with a decreased penicillin acylation rate (2), (ii) a mutation in the mtrCDE efflux pump (mtr) promoter that increases pump expression (3), and (iii) mutations in the porin P1B allele that decrease porin-mediated influx of penicillin (4). An L421P substitution in PBP1, encoded by ponA, also plays a role in decreased susceptibility (5). To contribute to the understanding of mutations that reduce penicillin susceptibility, we sequenced the genomes of three strains with different levels of resistance.
N. gonorrhoeae strains 111, 114, and 151 were isolated from infected individuals in Cincinnati, Ohio, in 1994 and were provided by Joan Knapp at the Centers for Disease Control and Prevention (CDC). Bacteria were cultivated on GC agar base medium supplemented with 1% Kellogg’s solution (6) at 37°C in 5% CO2. Susceptibility testing was conducted as previously described (7); all isolates were resistant to penicillin, as determined using the Clinical and Laboratory Standards Institute cutoff of ≥2 μg/ml (8), with MICs from 4 to 32 μg/ml (Table 1).
TABLE 1
TABLE 1 Strain attributes, genome assembly overview, and identified penicillin resistance determinantsa
AttributeData for strain:
111114151
Collection locationCincinnati, OhioCincinnati, OhioCincinnati, Ohio
Yr199419941994
Total length (bp)2,089,4772,092,0332,196,466
No. of contigs857989
Coverage (×)229.26374.19445.25
N50 (bp)67,04176,83872,221
No. of coding domains2,0652,0572,192
No. of tRNAs505048
GC content (%)52.6752.6652.36
SRA accession no.SRR13215678SRR13215677SRR13215676
GenBank accession no.JAEEFU000000000.1JAEEFT000000000.1JAEEFS000000000.1
PEN MIC (μg/ml)4632
penA mutationsD345a, F504L, A510V, A516G, P551SD345a, F504L, A510V, A516G, P551SD345a, F504L, A510V, A516G
porB mutationsporB1b: G120K, A121DporB1b: G120K, A121DporB1a: WT
mtrR mutationsWTWTA39T
mtr promoter mutationsA-deletionA-deletionWT
ponA mutationsL421PL421PWT
blaTEMNoNoYes
a
PEN, penicillin; WT, wild-type allele. All assembly statistics are based on contigs of ≥500 bp.
Cells were grown overnight on agar plates, and genomic DNA was purified using the Thermo Fisher PureLink genomic DNA minikit following lysis in Tris-EDTA buffer with 0.5 mg/ml lysozyme and 3 mg/ml proteinase K. Illumina Nextera XT-prepared libraries were pooled and sequenced using a V3 600-cycle cartridge (2 × 300 bp) on the Illumina MiSeq platform at the Rochester Institute of Technology Genomics Core. For all analyses, default parameters were used except where otherwise noted. Paired-end sequencing resulted in a total of 7.97 million reads across the three samples, and after poor quality sequences were trimmed using Trimmomatic v.0.39 (9), a total of 7.46 million reads remained. SPAdes v.3.13.0 (10) was used for assembly, statistics were reported using QUAST (11), and genes were annotated with Prokka v.1.14.5 (12) (Table 1). We identified resistance mutations by alignment to FA6140 (GenBank accession number CP012027.1) and FA19 (CP012026.1) sequences using BLASTn. To identify the phylogenetic placement of new genomes, we reconstructed the phylogeny of 2,652 gonococcal strains isolated in the United States between 1983 and 2016 (1316) (Fig. 1). An alignment was created by mapping to NCCP11945 (NC_011035.1) (see reference 17), and Gubbins v.2.4.1 (18), RAxML v.8.2.12 (19), and iTOL v.5 (20) were used to construct and visualize the tree.
FIG 1
FIG 1 Maximum likelihood whole-genome-based phylogeny of 2,652 N. gonorrhoeae strains collected in the United States between 1983 and 2016. This tree includes 1,102 isolates collected by the Gonococcal Isolate Surveillance Project (GISP) between 2000 and 2013 (13), 649 isolates collected by GISP between 2014 and 2016 (14), 897 isolates collected by the New York City Department of Health and Mental Hygiene between 2011 and 2015 (15), FA6140 (16), and the strains published in this study. Of the newly sequenced strains, 111 and 114 are two of the nearest phylogenetic neighbors to FA6140, a strain that as yet has an unclear mechanism of resistance to penicillin. The purple arrow indicates the position of FA6140 on the tree, and the blue arrows indicate the positions of the strains sequenced in this study.
Isolates 111 and 114 had penicillin MICs of 4 and 6 μg/ml, respectively, and did not harbor the β-lactamase gene, suggesting that they are similar to the CMRNG strain FA6140. Indeed, out of the 2,652 strains in our cohort, these isolates were among the nearest phylogenetic neighbors to FA6140 (Fig. 1), despite isolation 11 years later from a distinct geographic location. The number of polymorphic sites from the FA6140 reference genome was 484 and 465 for 111 and 114, respectively. These isolates had the same haplotype of known resistance determinants as FA6140 (Table 1).
Strain 151 had a penicillin MIC of 32 μg/ml, and analysis confirmed the presence of blaTEM-1, indicating that it is a penicillinase-producing strain. The assembly contained a 5,727-bp contig that differed by only two insertions from the top BLAST hit (GenBank accession number MH140435.1), the African-type pJD5 gonococcal plasmid (21). In addition, 151 had an mtrR A39T substitution, which increases the expression of mtrCDE (22) (Table 1), and substitutions in penA (Table 1), but these are likely minor contributors to resistance in this strain.
Future comparative analyses of the CMRNG genomes reported in this announcement may help to further illuminate the genetic basis of penicillin resistance in gonococci.

Data availability.

The accession numbers for genome assemblies and raw reads are listed in Table 1 and available for download through GenBank and the SRA, respectively. All code is accessible at https://github.com/wadsworthlab.

ACKNOWLEDGMENTS

We thank the College of Science (COS) at the Rochester Institute of Technology (RIT) for providing funding for this work through a Dean’s Research Initiation Grant (D-RIG). This work was also supported by National Institutes of Health Awards NIAID F32AI145157 (T.D.M.) and NIAID R21AI133004 (R.A.N.).
We thank Yonatan H. Grad at the Harvard T. H. Chan School of Public Health for generously providing feedback on this project and an earlier version of the manuscript.

REFERENCES

1.
Faruki H, Kohmescher RN, McKinney WP, Sparling PF. 1985. A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med 313:607–611.
2.
Spratt BG. 1988. Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae. Nature 332:173–176.
3.
Hagman KE, Pan W, Spratt BG, Balthazar JT, Judd RC, Shafer WM. 1995. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141:611–622.
4.
Gill MJ, Simjee S, Al-Hattawi K, Robertson BD, Easmon CSF, Ison CA. 1998. Gonococcal resistance to β-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antimicrob Agents Chemother 42:2799–2803.
5.
Ropp PA, Hu M, Olesky M, Nicholas RA. 2002. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penc, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 46:769–777.
6.
Kellogg DS, Peacock WL, Deacon WE, Brown L, Pirkle DI. 1963. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J Bacteriol 85:1274–1279.
7.
Fiore MA, Raisman JC, Wong NH, Hudson AO, Wadsworth CB. 2020. Exploration of the Neisseria resistome reveals resistance mechanisms in commensals that may be acquired by N. gonorrhoeae through horizontal gene transfer. Antibiotics 9:656–672.
8.
Clinical Laboratory Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing, 29th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute, Wayne, PA.
9.
Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120.
10.
Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477.
11.
Gurevich A, Saveliev V, Vyahhi N, Tesler G. 2013. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29:1072–1075.
12.
Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069.
13.
Grad YH, Harris SR, Kirkcaldy RD, Green AG, Marks DS, Bentley SD, Trees D, Lipsitch M. 2016. Genomic epidemiology of gonococcal resistance to extended-spectrum cephalosporins, macrolides, and fluoroquinolones in the United States, 2000–2013. J Infect Dis 214:1579–1587.
14.
Thomas JC, Seby S, Abrams AJ, Cartee J, Lucking S, Vidyaprakash E, Schmerer M, Pham CD, Hong J, Torrone E, Cyr SS, Shafer WM, Bernstein K, Kersh EN, Gernert KM, Weinstock H, Dominguez C, Hun S, Kneupper K, Antimicrobial-Resistant Neisseria gonorrhoeae Working Group. 2019. Evidence of recent genomic evolution in gonococcal strains with decreased susceptibility to cephalosporins or azithromycin in the United States, 2014–2016. J Infect Dis 220:294–305.
15.
Mortimer TD, Pathela P, Crawley A, Rakeman JL, Lin Y, Harris SR, Blank S, Schillinger JA, Grad YH. 2020. The distribution and spread of susceptible and resistant Neisseria gonorrhoeae across demographic groups in a major metropolitan center. Clin Infect Dis.
16.
Abrams AJ, Trees DL, Nicholas RA. 2015. Complete genome sequences of three Neisseria gonorrhoeae laboratory reference strains, determined using PacBio single-molecule real-time technology. Genome Announc 3:e01052-15.
17.
Ma KC, Mortimer TD, Hicks AL, Wheeler NE, Sánchez-Busó L, Golparian D, Taiaroa G, Rubin DHF, Wang Y, Williamson DA, Unemo M, Harris SR, Grad YH. 2020. Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae. Nat Commun 11:1–11.
18.
Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, Parkhill J, Harris SR. 2015. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 43:e15.
19.
Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30:1312–1313.
20.
Letunic I, Bork P. 2019. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res 47:W256–W259.
21.
Pagotto F, Aman A-T, Ng L-K, Yeung K-H, Brett M, Dillon J-AR. 2000. Sequence analysis of the family of penicillinase-producing plasmids of Neisseria gonorrhoeae. Plasmid 43:24–34.
22.
Shafer WM, Balthazar JT, Hagman KE, Morse SA. 1995. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology 141:907–911.

Information & Contributors

Information

Published In

cover image Microbiology Resource Announcements
Microbiology Resource Announcements
Volume 10Number 1118 March 2021
eLocator: 10.1128/mra.00074-21
Editor: Julie C. Dunning Hotopp, University of Maryland School of Medicine
PubMed: 33737358

History

Received: 25 January 2021
Accepted: 26 February 2021
Published online: 18 March 2021

Contributors

Authors

Thomas C. Murphy
Rochester Institute of Technology, Thomas H. Gosnell School of Life Sciences, Rochester, New York, USA
Tatum D. Mortimer
Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA
Robert A. Nicholas
Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Rochester Institute of Technology, Thomas H. Gosnell School of Life Sciences, Rochester, New York, USA

Editor

Julie C. Dunning Hotopp
Editor
University of Maryland School of Medicine

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy